Pathophysiology of metalloproteinase matrix in relation to morbid obesity and associated pathologies-Reference-Cited by-同舟云学术

Pathophysiology of metalloproteinase matrix in relation to morbid obesity and associated pathologies

Published:2022-05-04 Issue:3 Volume:8 Page:411-419
ISSN:2149-3189
Container-title:The European Research Journal
language:
Short-container-title:

Author:

MİRİCA Radu Mihail,IONESCU Mihai,MIRICA Alexandra,GINGHINA Octav,IOSIFESCU Razvan,VACARASU Andrei- Bogdan,CIOTARLA Danut- Constantin,ROSCA Adrian,ZAGREAN Leon,IORDACHE Niculae

Publisher

The European Research Journal

Reference63 articles.

1. 1. Lee YJ, Heo YS, Park HS, Lee SH, Lee SK, Jang YJ. Serum SPARC and matrix metalloproteinase-2 and metalloproteinase-9 concentrations after bariatric surgery in obese adults. Obes Surg 2014;24:604-10.

2. 2. Sternlicht MD, Werb Z. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 2001;17:463-516.

3. 3. Ress C, Tschoner A, Ciardi C, Laimer MW, Engl JW, Sturm W, et al. Influence of significant weight loss on serum matrix metalloproteinase (MMP)-7 levels. Eur Cytokine Netw 2010;21:65-70.

4. 4. Deng ZB, Liu Y, Liu C, Xiang X, Wang J, Cheng Z, et al. Immature myeloid cells induced by a high-fat diet contribute to liver inflammation. Hepatology 2009;50:1412-20.

5. 5. Popov Y, Schuppan D. Targeting liver fibrosis: strategies for development and validation of antifibrotic therapies. Hepatology 2009;50:1294-306.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Implications of the Matrix Metalloproteinases, Their Tissue Inhibitors and Some Other Inflammatory Mediators Expression Levels in Children Obesity-Related Phenotypes;Journal of Personalized Medicine;2024-03-19